Clinical and epidemiological characterization of patients with hepatocarcinoma

Introduction and Objectives: Hepatocellular carcinoma (HCC) represents more than 80% of liver cancers with a direct impact on morbidity and mortality. Viral hepatitis is responsible for most cases, in addition to the progression of liver cirrhosis from other causes. There are various risk factors of...

Full description

Bibliographic Details
Main Authors: Lissa M. Cruz-Rodríguez, Aranzazú G. Pérez-Castañeda, Jaime I. Cervantes-Contreras, Edgar S. García-Jiménez, Juan M. Aldana-Ledesma, José A. Velarde-Ruiz Velasco
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268124002217
_version_ 1827325508770070528
author Lissa M. Cruz-Rodríguez
Aranzazú G. Pérez-Castañeda
Jaime I. Cervantes-Contreras
Edgar S. García-Jiménez
Juan M. Aldana-Ledesma
José A. Velarde-Ruiz Velasco
author_facet Lissa M. Cruz-Rodríguez
Aranzazú G. Pérez-Castañeda
Jaime I. Cervantes-Contreras
Edgar S. García-Jiménez
Juan M. Aldana-Ledesma
José A. Velarde-Ruiz Velasco
author_sort Lissa M. Cruz-Rodríguez
collection DOAJ
description Introduction and Objectives: Hepatocellular carcinoma (HCC) represents more than 80% of liver cancers with a direct impact on morbidity and mortality. Viral hepatitis is responsible for most cases, in addition to the progression of liver cirrhosis from other causes. There are various risk factors of importance for identification and screening programs for adults at risk of HCC. The aim of this study was to characterize the clinical and epidemiological profile of patients diagnosed with HCC. Materials and Patients: Prospective study of patients diagnosed with HCC. Data from clinical history, laboratory results, histopathology, and imaging studies were obtained. Univariate analyzes were carried out and Kolmogorov-Smirnov and Shapiro-Wilk normality tests were performed for continuous variables to determine the appropriate statistical test, performing bivariate analyzes with the Mann-Whitney or T-Student test. Non-parametric correlations were determined by Rho Spearman calculated with a 95% confidence interval and statistical significance p<0.05. Results: We identified 50 patients (n=50) with HCC with a mean age of diagnosis 66 years (SD ± 12.91), 70% predominating in men and 88% with liver cirrhosis, the majority being Child-Pugh C (34%). The main etiology of liver cirrhosis was hepatitis C (42%) and alcohol consumption (30%); others were MASLD 4% and hepatitis B 4%. The performance status by ECOG scale was (0-2) in 70% and (3-4) in 30%. Most patients were identified in Barcelona (BCLC) D (38%) and all were diagnosed by imaging criteria or histopathology combined AFP (alpha-fetoprotein) levels. Biopsies were performed in 34% of the patients, with a predominance of moderately differentiated type (14%), identifying metastases in 8%. Mortality was 28% presenting statistical significance with AFP levels (p=0.028) and hepatic encephalopathy (p=0.004). The ECOG scale showed a positive correlation with the presence of ascites (r=.567, p= <0.001), hepatic encephalopathy (r=.337, p=0.017) and Child-Pugh Scale (r=0.615, p=<0.001). Conclusions: Most cases were identified at an advanced stage, highlighting the importance of early detection, with screening programs focused on eliminating risk factors, treatment of viral hepatitis, cessation of alcohol consumption, and periodic follow-up of patients with liver cirrhosis to prevent disease progression and impacts on quality of life.
first_indexed 2024-03-07T14:30:17Z
format Article
id doaj.art-a33d6ee06fa443ed9e70c9b04621c6d4
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-03-07T14:30:17Z
publishDate 2024-02-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-a33d6ee06fa443ed9e70c9b04621c6d42024-03-06T05:26:06ZengElsevierAnnals of Hepatology1665-26812024-02-0129101427Clinical and epidemiological characterization of patients with hepatocarcinomaLissa M. Cruz-Rodríguez0Aranzazú G. Pérez-Castañeda1Jaime I. Cervantes-Contreras2Edgar S. García-Jiménez3Juan M. Aldana-Ledesma4José A. Velarde-Ruiz Velasco5Gastroenterology, Hospital Civil de Guadalajara Fray Antonio Alcalde, MéxicoGastroenterology, Hospital Civil de Guadalajara Fray Antonio Alcalde, MéxicoGastroenterology, Hospital Civil de Guadalajara Fray Antonio Alcalde, MéxicoGastroenterology, Hospital Civil de Guadalajara Fray Antonio Alcalde, MéxicoGastroenterology, Hospital Civil de Guadalajara Fray Antonio Alcalde, MéxicoGastroenterology, Hospital Civil de Guadalajara Fray Antonio Alcalde, MéxicoIntroduction and Objectives: Hepatocellular carcinoma (HCC) represents more than 80% of liver cancers with a direct impact on morbidity and mortality. Viral hepatitis is responsible for most cases, in addition to the progression of liver cirrhosis from other causes. There are various risk factors of importance for identification and screening programs for adults at risk of HCC. The aim of this study was to characterize the clinical and epidemiological profile of patients diagnosed with HCC. Materials and Patients: Prospective study of patients diagnosed with HCC. Data from clinical history, laboratory results, histopathology, and imaging studies were obtained. Univariate analyzes were carried out and Kolmogorov-Smirnov and Shapiro-Wilk normality tests were performed for continuous variables to determine the appropriate statistical test, performing bivariate analyzes with the Mann-Whitney or T-Student test. Non-parametric correlations were determined by Rho Spearman calculated with a 95% confidence interval and statistical significance p<0.05. Results: We identified 50 patients (n=50) with HCC with a mean age of diagnosis 66 years (SD ± 12.91), 70% predominating in men and 88% with liver cirrhosis, the majority being Child-Pugh C (34%). The main etiology of liver cirrhosis was hepatitis C (42%) and alcohol consumption (30%); others were MASLD 4% and hepatitis B 4%. The performance status by ECOG scale was (0-2) in 70% and (3-4) in 30%. Most patients were identified in Barcelona (BCLC) D (38%) and all were diagnosed by imaging criteria or histopathology combined AFP (alpha-fetoprotein) levels. Biopsies were performed in 34% of the patients, with a predominance of moderately differentiated type (14%), identifying metastases in 8%. Mortality was 28% presenting statistical significance with AFP levels (p=0.028) and hepatic encephalopathy (p=0.004). The ECOG scale showed a positive correlation with the presence of ascites (r=.567, p= <0.001), hepatic encephalopathy (r=.337, p=0.017) and Child-Pugh Scale (r=0.615, p=<0.001). Conclusions: Most cases were identified at an advanced stage, highlighting the importance of early detection, with screening programs focused on eliminating risk factors, treatment of viral hepatitis, cessation of alcohol consumption, and periodic follow-up of patients with liver cirrhosis to prevent disease progression and impacts on quality of life.http://www.sciencedirect.com/science/article/pii/S1665268124002217
spellingShingle Lissa M. Cruz-Rodríguez
Aranzazú G. Pérez-Castañeda
Jaime I. Cervantes-Contreras
Edgar S. García-Jiménez
Juan M. Aldana-Ledesma
José A. Velarde-Ruiz Velasco
Clinical and epidemiological characterization of patients with hepatocarcinoma
Annals of Hepatology
title Clinical and epidemiological characterization of patients with hepatocarcinoma
title_full Clinical and epidemiological characterization of patients with hepatocarcinoma
title_fullStr Clinical and epidemiological characterization of patients with hepatocarcinoma
title_full_unstemmed Clinical and epidemiological characterization of patients with hepatocarcinoma
title_short Clinical and epidemiological characterization of patients with hepatocarcinoma
title_sort clinical and epidemiological characterization of patients with hepatocarcinoma
url http://www.sciencedirect.com/science/article/pii/S1665268124002217
work_keys_str_mv AT lissamcruzrodriguez clinicalandepidemiologicalcharacterizationofpatientswithhepatocarcinoma
AT aranzazugperezcastaneda clinicalandepidemiologicalcharacterizationofpatientswithhepatocarcinoma
AT jaimeicervantescontreras clinicalandepidemiologicalcharacterizationofpatientswithhepatocarcinoma
AT edgarsgarciajimenez clinicalandepidemiologicalcharacterizationofpatientswithhepatocarcinoma
AT juanmaldanaledesma clinicalandepidemiologicalcharacterizationofpatientswithhepatocarcinoma
AT joseavelarderuizvelasco clinicalandepidemiologicalcharacterizationofpatientswithhepatocarcinoma